- Home
- MLYS vs CAC Comparison
MLYS vs CAC Comparison
Compare MLYS & CAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- CAC
- Stock Information
- Founded
- MLYS 2019
- CAC 1875
- Country
- MLYS United States
- CAC United States
- Employees
- MLYS N/A
- CAC N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- CAC Major Banks
- Sector
- MLYS Health Care
- CAC Finance
- Exchange
- MLYS Nasdaq
- CAC Nasdaq
- Market Cap
- MLYS 890.6M
- CAC 688.3M
- IPO Year
- MLYS 2023
- CAC 1997
- Fundamental
- Price
- MLYS $36.21
- CAC $40.26
- Analyst Decision
- MLYS Strong Buy
- CAC Buy
- Analyst Count
- MLYS 6
- CAC 3
- Target Price
- MLYS $42.60
- CAC $48.00
- AVG Volume (30 Days)
- MLYS 2.6M
- CAC 54.0K
- Earning Date
- MLYS 11-10-2025
- CAC 10-28-2025
- Dividend Yield
- MLYS N/A
- CAC 4.17%
- EPS Growth
- MLYS N/A
- CAC 4.80
- EPS
- MLYS N/A
- CAC 3.11
- Revenue
- MLYS N/A
- CAC $197,501,000.00
- Revenue This Year
- MLYS N/A
- CAC $42.11
- Revenue Next Year
- MLYS N/A
- CAC $5.51
- P/E Ratio
- MLYS N/A
- CAC $12.93
- Revenue Growth
- MLYS N/A
- CAC 21.74
- 52 Week Low
- MLYS $8.24
- CAC $34.53
- 52 Week High
- MLYS $39.20
- CAC $50.07
- Technical
- Relative Strength Index (RSI)
- MLYS 82.25
- CAC 51.56
- Support Level
- MLYS $35.00
- CAC $39.82
- Resistance Level
- MLYS $39.20
- CAC $40.77
- Average True Range (ATR)
- MLYS 2.65
- CAC 0.85
- MACD
- MLYS 1.31
- CAC -0.01
- Stochastic Oscillator
- MLYS 87.88
- CAC 35.52
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.